| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Tyra Biosciences, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 200,000 | 07 Aug 2025 | Direct | ||
| eFFECTOR Therapeutics, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 25,000 | 19 Feb 2024 | Direct | ||
| Tyra Biosciences, Inc. | Chief Medical Officer | No securities are beneficially owned. | 0 | 09 Sep 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TYRA | Tyra Biosciences, Inc. | 07 Aug 2025 | 1 | $0 | 4 | Chief Medical Officer | 07 Aug 2025, 16:38 |
| TYRA | Tyra Biosciences, Inc. | 09 Sep 2024 | 1 | $0 | 4 | Chief Medical Officer | 10 Sep 2024, 16:53 |
| TYRA | Tyra Biosciences, Inc. | 09 Sep 2024 | 0 | $0 | 3 | Chief Medical Officer | 10 Sep 2024, 16:49 |
| /report/000120919124003673-warner-douglas-j-2024-02-19 | eFFECTOR Therapeutics, Inc. | 19 Feb 2024 | 1 | $0 | 4 | Chief Medical Officer | 21 Feb 2024, 17:00 |
| /report/000120919123004050-warner-douglas-j-2023-01-17 | eFFECTOR Therapeutics, Inc. | 17 Jan 2023 | 1 | $0 | 4 | Chief Medical Officer | 19 Jan 2023, 16:07 |
| /report/000120919122044874-warner-douglas-j-2022-08-08 | eFFECTOR Therapeutics, Inc. | 08 Aug 2022 | 1 | $0 | 4 | Chief Medical Officer | 08 Aug 2022, 18:17 |
| /report/000120919122044861-warner-douglas-j-2022-08-08 | eFFECTOR Therapeutics, Inc. | 08 Aug 2022 | 0 | $0 | 3 | Chief Medical Officer | 08 Aug 2022, 17:52 |